Led by the World Health Organisation’s Uppsala Monitoring Centre, Work Package 2b is aiming to develop and link new and existing analytical tools for the analysis of social media content for pharmacovigilance purposes. WP2b will therefore improve the quality and relevance of data extracted from social media sources, as well as their subsequent use in the detection of safety signals. WP2b is focusing on: suspected ADR identification, record linkage of duplicate reports, and signal detection.

Partners involved

  • Uppsala Monitoring Centre
  • University of Liverpool
  • Epidemico
  • Novartis Pharma
  • Janssen Pharmaceutica
  • Bayer
  • AstraZeneca
  • UCB
  • Sanofi-Aventis Research & Development